Yellow Cake begins Share Buyback Programme
Summary by AI BETAClose X
15 June 2026
Yellow Cake plc ("Yellow Cake", the "Company" or "Group")
Yellow Cake begins US$10 million Share Buyback Programme
Yellow Cake, a specialist Group operating in the uranium sector, holding physical uranium ("U3O8") for the long term and engaged in uranium-related commercial activities, announces the initiation of a share buyback programme to purchase up to US$10 million of the Company's ordinary shares with a nominal value of £0.01 each ("Ordinary Shares") over 60 calendar days commencing on 15 June 2026 (the "Programme").
The Yellow Cake Board has noted the recent widening of the discount at which the Company's shares have traded relative to its underlying net asset value ("NAV"). The Board believes that the current share price represents an attractive opportunity to increase shareholders' exposure to the Company's uranium holdings at a discount to their underlying value and that a share buyback programme is an efficient means of creating value for shareholders.
The Board continues to have confidence in the long-term fundamentals of the uranium market and believes the Company's physical uranium holdings provide shareholders with direct exposure to those fundamentals. The Company remains well capitalised, with a strong balance sheet and significant liquidity.
The Programme forms part of the Company's broader stated strategy to enhance shareholder value.
Buyback Programme
Purchases pursuant to the Programme will be made under the authority the Company has in place to make market acquisitions in accordance with the Jersey Companies Law and the authority granted by Shareholders to the Board of the Company at its Annual General Meeting, held on 4 September 2025 (the "Existing Authority"). The Existing Authority permits the purchase of a maximum of 21,685,645 Ordinary Shares. The Programme, the purpose of which is to reduce the Company's issued share capital, will take place within the limitations of the Existing Authority.
Under the parameters of the Programme, the Company will seek to make market purchases at prices and volumes that the Company believes to be value-enhancing for the Company's shareholders. As such, it is the Company's intention that Ordinary Shares will only be purchased should the closing mid-market share price of the Company, on the prior day to any such purchases being made, represent a discount of 10% or more to the Company's proforma Net Asset Value at that time. The Programme will be implemented over 60 calendar days unless extended by the Company.
The Programme will be conducted in compliance with the Market Abuse Regulation (EU) No. 596/2014 and Commission Delegated Regulation (EU) No. 2016/1052, as they form part of UK law. The Company intends to hold those Ordinary Shares purchased under the Programme in treasury.
Purchases will be carried out in compliance with the relevant conditions for trading, restrictions regarding time and volume, disclosure and reporting obligations, and price conditions. The Ordinary Shares will be repurchased at a price, excluding expenses, that does not exceed the higher of (i) the last independent trade or the highest current independent bid on the relevant trading platform; and (ii) 105 percent of the average market value of an Ordinary Share as derived from the AIM Appendix to the London Stock Exchange Daily Official List for the five business days immediately preceding the date of purchase.
Yellow Cake has entered into an agreement with the Company's Broker, Canaccord Genuity Limited ("Canaccord"), to carry out on-market purchases of its Ordinary Shares. Canaccord will act as riskless principal and will make trading decisions concerning the timing of the purchases of Ordinary Shares independently of the Company.
Details of any purchases made under the Programme will be provided via RNS announcements and published on the Company's website.
Andre Liebenberg, CEO of Yellow Cake said:
"We remain confident in the long-term outlook for uranium and continue to believe that Yellow Cake provides investors with a compelling means of gaining exposure to the commodity. At the current discount to NAV, we believe share repurchases represent an attractive opportunity to create value for shareholders and to increase their exposure to our uranium holdings at a discount to their underlying value."
ENQUIRIES:
|
Yellow Cake plc |
|
|
|
Andre Liebenberg, CEO |
Carole Whittall, CFO |
|
|
Tel: +44 (0) 153 488 5200 |
|
|
|
|
|
|
|
Nominated Adviser and Joint Broker: Canaccord Genuity Limited |
|
|
|
James Asensio |
Henry Fitzgerald-O'Connor |
|
|
Charlie Hammond |
|
|
|
Tel: +44 (0) 207 523 8000 |
|
|
|
|
|
|
|
Joint Broker: Berenberg |
|
|
|
Matthew Armitt |
Jennifer Lee |
|
|
Detlir Elezi |
|
|
|
Tel: +44 (0) 203 207 7800 |
|
|
|
|
|
|
|
Financial Adviser: Bacchus Capital Advisers |
||
|
Peter Bacchus |
Richard Allan |
|
|
Tel: +44 (0) 203 848 1640 |
|
|
|
|
|
|
|
Communications Adviser: Sodali & Co |
|
|
|
Peter Ogden |
James Whitaker |
|
|
Tel: +44 (0) 7793 858 211 |
|
|
|
|
|
|
|
|
|
|
ABOUT YELLOW CAKE
Yellow Cake is a London-quoted company, headquartered in Jersey, which offers exposure to the uranium spot price. This is achieved through its strategy of buying and holding physical triuranium octoxide ("U3O8"). It may also seek to add value through other uranium-related activities. Yellow Cake and its wholly owned subsidiary (together, the "Group") seek to generate returns for shareholders through the appreciation of the value of its holding of U3O8 and its other uranium-related activities in a rising uranium price environment. The business is differentiated from its peers by its ten-year Framework Agreement for the supply of U3O8 with Kazatomprom, the world's largest uranium producer. The Group currently holds 23.11 million pounds of U3O8, all of which is held in storage in Canada and France.
FORWARD LOOKING STATEMENTS
Certain statements contained herein are forward looking statements and are based on current expectations, estimates and projections about the potential returns of the Group and the industry and markets in which the Group will operate, the Directors' beliefs and assumptions made by the Directors. Words such as "expects", "anticipates", "should", "intends", "plans", "believes", "seeks", "estimates", "projects", "pipeline", "aims", "may", "targets", "would", "could" and variations of such words and similar expressions are intended to identify such forward looking statements and expectations. These statements are not guarantees of future performance or the ability to identify and consummate investments and involve certain risks, uncertainties and assumptions that are difficult to predict, qualify or quantify. Therefore, actual outcomes and results may differ materially from what is expressed in such forward looking statements or expectations. Among the factors that could cause actual results to differ materially are: uranium price volatility, difficulty in sourcing opportunities to buy or sell U3O8, foreign exchange rates, changes in political and economic conditions, competition from other energy sources, nuclear accident, loss of key personnel or termination of the services agreement with 308 Services Limited, changes in the legal or regulatory environment, insolvency of counterparties to the Group's material contracts or breach of such material contracts by such counterparties. These forward-looking statements speak only as at the date of this announcement. The Group expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based unless required to do so by applicable law or the AIM Rules.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 7 hours ago Luceco
- 7 hours ago Helios Towers
- 8 hours ago Wise Class A
- 8 hours ago EDX Medical Group Plc
- 8 hours ago Naked Wines